Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 4
- Mary Ann Liebert, Inc. to Publish Journal of Correctional Health Care
- 10/23/2020 5:36:48 PM
- The National Commission on Correctional Health Care (NCCHC) has awarded the contract to publish Journal of Correctional Health Care to Mary Ann Liebert, Inc., publishers, effective January 2021.
- 11 UCSF Research Specialties Rank in Top 10 in US News Global Universities Rankings for 2021
- 10/23/2020 1:09:01 PM
- UC San Francisco has 11 specialties ranked in the top 10 in U.S. News & World Report ’s Best Global Universities 2021 rankings. Now in their seventh year, the Best Global Universities rankings focus on schools’ academic research and reputation overall instead of specific undergraduate and graduate programs.
- We’ve supported Malaysian companies’ fight against COVID-19
- 10/22/2020 8:49:39 AM
- As the battle against COVID-19 continues, Bodibasixs Manufacturing Sdn Bhd, KTMG Limited and Sin Huat Press (Melaka) Sdn Bhd are contributing to the international effort to enable greater access to medical supplies with support from Standard Chartered’s USD1 billion not-for-profit financing.
- Thanks to an EU funded project, UNESCO and CMC signed the exchanging letters of establishing the Fact Checking Tools (FCT) platform to fight disinformation and fake news amid COVID-19
- 10/22/2020 8:07:14 AM
- Signature of the Fact Checking Tools Platform of Iraq UNESCO and CMC signed the exchanging letters of establishing the FCT Fact Checking Tools Platform to fight Disinformation and fake news amid COVID-19, as part of the EU funded project “#CoronavirusFacts: Addressing the ‘Disinfodemic’ on Covid-19 in conflict-prone environments” project.
- “Pain Culprits!” an Amazon Best-Selling Book is Free For One More Day (until 10/23/2020)
- 10/22/2020 6:00:00 AM
- Best Seller Publishing announces the release of Eileen Kopsaftis’s new book, “Pain Culprits!: Surprising Truths Behind Pain, How to Uncover the Cause, and What to Do about It.” It will be available for free download in the Amazon Kindle Store for one more day on October 23rd.
- First Peer-Reviewed Study Using Mission Bio’s Single-Cell DNA and Protein Capability Uniquely Reveals Clonal Diversity Underlying AML and Therapy Resistance
- 10/21/2020 6:24:58 PM
- Mission Bio, Inc., the pioneer in single-cell DNA and multi-omics analysis, today announced the publication of a study demonstrating the power of its Tapestri Platform® to establish the single-cell genomics atlas of acute myeloid leukemia (AML) samples, providing unique insight into disease evolution and treatment resistance.
- MBio Diagnostics Announces Rebrand to LightDeck Diagnostics to Reflect Commitment to Its Innovative Waveguide Product Platform
- 10/21/2020 5:15:21 PM
- MBio Diagnostics, the company taking the point-of-care anywhere with on-the-spot, central lab-quality diagnostics, announced today that it is changing its corporate name to LightDeck Diagnostics.
- Immunai Collaborates With Baylor College of Medicine To Develop Targeted, Effective Cancer Immunotherapies
- 10/21/2020 1:59:51 PM
- Immunai, the company decoding the immune system, is collaborating with Baylor College of Medicine, the premier academic health sciences center, to bring more targeted and effective cancer therapies to market.
- WHO 2020 Global TB Report app – now available in English, French and Russian
- 10/21/2020 8:27:49 AM
- The new version of the World Health Organization (WHO) 2020 Global TB Report app is now available for your smartphone and tablet. The game-changing app brings to the users’ fingertips the latest TB statistics and trends, country and region comparisons and quick search for indicators.
- Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment
- 10/20/2020 1:36:29 PM
- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, today announced that its Biotech division has entered into a strategic collaboration with Synairgen plc, a respiratory drug discovery and development company, to conduct a pivotal phase III study of an …
- GreenWood, Inc. Achieves 1.5 Million Safe Work Hours at Mitsubishi Polyester Film
- 10/20/2020 11:59:45 AM
- GreenWood, Inc., an integrated maintenance, operations and construction solutions provider, has achieved 1.5 million safe work hours at their Mitsubishi Polyester Film project in Greer, South Carolina. The accomplishment was reached after thirteen years of performance without a lost time event where GreenWood provides capital project work and supplemental maintenance for …
- Forxiga recommended for approval in the EU by CHMP for heart failure
- 10/19/2020 1:57:11 PM
- AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults with and without type-2 diabetes (T2D).
- CBD helps reduce lung damage from COVID by increasing levels of protective peptide
- 10/19/2020 8:17:40 AM
- One way CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.
- “Pain Culprits!” is Now Free on Amazon for 5 Days (until 10/23/2020)
- 10/19/2020 6:00:00 AM
- Best Seller Publishing announces the release of Eileen Kopsaftis’s new book, “Pain Culprits!: Surprising Truths Behind Pain, How to Uncover the Cause, and What to Do about It.” It will be available for free download in the Amazon Kindle Store on October 19th.
- Peer-Reviewed Report Examines Pre-Exposure Prophylaxis for COVID-19
- 10/18/2020 8:38:16 PM
- Borrowing from successful malaria and HIV/AIDS prophylaxis, a new report suggests rethinking the use of a controversial Food and Drug Administration (FDA)-approved medication to avoid severe viral infection and death from COVID-19.
- Eileen Kopsaftis’s “Pain Culprits!” - Free Download Tomorrow (10/19/2020)
- 10/18/2020 6:00:00 AM
- Best Seller Publishing announces the release of Eileen Kopsaftis’s new book, “Pain Culprits!: Surprising Truths Behind Pain, How to Uncover the Cause, and What to Do about It.” It will be available for free download in the Amazon Kindle Store on October 19th.
- NIH Begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19
- 10/16/2020 6:08:11 PM
- The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
- ‘Heat-not-burn’ Alternative to E-cigarettes May Harm Heart
- 10/16/2020 5:45:37 PM
- A new review suggests “heat-not-burn” tobacco devices may threaten cardiovascular health. The review is published ahead of print in the American Journal of Physiology-Heart and Circulatory Physiology.
- Promising COVID-19 Research Awards Announced by American Lung Association, Clinical Trials Expanded with COVID-19 Research
- 10/16/2020 5:34:17 PM
- As the COVID-19 pandemic reached the United States, the American Lung Association announced the COVID-19 Action Initiative, designed to accelerate the search for COVID-19 solutions.
- Astrocytes build synapses after cocaine use in mice
- 10/16/2020 12:37:12 PM
- Drugs of abuse, like cocaine, are so addictive due in part to their cellular interaction, creating strong cellular memories in the brain that promote compulsive behaviors.
